×

Apparatus for improving blood sugar control in diabetics

  • US 4,475,901 A
  • Filed: 11/06/1981
  • Issued: 10/09/1984
  • Est. Priority Date: 07/23/1980
  • Status: Expired due to Fees
First Claim
Patent Images

1. A hybrid open loop/closed loop infusion system comprising an infusion means and a control means connected thereto to control the operation of said infusion means, wherein said infusion means comprises a first pump connected between a first diabetic control liquid reservoir and a tissue access system adapted to be connected to the body of a patient whereby a first diabetic control liquid from said reservoir is infused into said body via said access system;

  • and a second pump connected between a second diabetic control liquid reservoir and said access system whereby a second diabetic control liquid from said second reservoir is infused into said body via said access system; and

    wherein said control means comprises a basal rate means, a meal rate means, a hyperglycaemic rate means, a hypoglycaemic rate means, a patient blood data entry means and a patient factor entry means;

    said basal rate means operating said first pump in an open loop mode at a base rate corresponding to an anticipated assessed basal metabolic requirement of said patient, said meal rate means increasing the open loop mode operation of said first pump by predetermined amounts over a predetermined time corresponding to anticipated ingestion of food by, or physical activity of, said patient, said patient blood data entry means being adapted to receive and store patient blood data derived from at least one of a plurality of successive patient blood samplings each taken after an interval of the order of one hour since the previous patient blood sampling and operating said first pump in a quasi-closed loop feedback mode at a first rate dependent upon said blood data but between a predetermined maximum first rate and a predetermined minimum first rate, said patient being able to be infused with safety at said first rate during said interval between successive samplings, said hyperglycaemic rate means operating said first pump at a predetermined hyperglycaemic rate in excess of said predetermined maximum first rate and operating said second pump at a zero or low rate, said hypoglycaemic rate means operating said first pump at a zero rate or a low rate less than said predetermined minimum first rate and operating said second pump at a hypoglycaemic rate, and said patient factor entry means being associated with said data entry means and adapted to receive and store a patient factor which varies from individual patient to individual patient;

    said predetermined maximum first rate and said predetermined minimum first rate controlled by said data entry means being adjusted by said patient factor entry means in accordance with said patient factor.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×